Capability benchmark · Biology · Medicine
EVE predicts disease variant effects from evolutionary sequence data
EVE predicts disease variant effects from evolutionary sequence data: capability signal for AI systems on research-adjacent tasks.
Summary
The Nature paper presents EVE, a deep generative model trained on evolutionary sequence data to estimate the pathogenicity of protein variants. The authors provide model predictions and code and evaluate the approach against clinical variant annotations and experimental datasets.
AI role
AI systems are tested on research-adjacent capabilities relevant to biology, medicine.
Narrative role
This is supporting evidence for whether AI systems can perform research-adjacent tasks needed before stronger discovery or acceleration claims.
Caveat
Benchmark, model, or tool performance is an upstream capability indicator, not proof of new scientific discovery.